Icad logo

Icad share price today

(ICAD)

Icad share price is $1.95 & ₹166.80 as on 30 Dec 2024, 20.04 hrs IST

$1.95

▲

0.09

(4.84%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Icad share price in Dollar and Rupees. Guide to invest in Icad from India. Also see the sentimental analysis on Indian investors investing in Icad. Get details on the Indian mutual funds that are investing in Icad. Get Analyst recommendations and forecasts along with all the Icad's financials.

Icad share price movements

  • Today's Low: $1.84
    Today's High: $1.96

    Day's Volatility :6.01%

  • 52 Weeks Low: $1.18
    52 Weeks High: $2.65

    52 Weeks Volatility :55.47%

Icad Returns

PeriodIcad IncSector (Health Care)Index (Russel 2000)
3 Months
24.6%
-9.8%
0.0%
6 Months
54.15%
-4.7%
0.0%
1 Year
5.98%
1.9%
0.0%
3 Years
-72.92%
-1.8%
-21.3%

Icad Key Statistics

in dollars & INR

Previous Close
$1.95
Open
$1.83
Today's High
$1.96
Today's Low
$1.8422
Market Capitalization
$49.0M
Today's Volume
$125.3K
52 Week High
$2.6499
52 Week Low
$1.18
Revenue TTM
$18.8M
EBITDA
$-4.7M
Earnings Per Share (EPS)
$-0.2
Profit Margin
-12.13%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-14.86%

How to invest in Icad from India?

It is very easy for Indian residents to invest directly in Icad from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Icad stock in both Indian Rupees (INR) and US Dollars (USD). Search for Icad or ICAD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Icad or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Icad shares which would translate to 0.439 fractional shares of Icad as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Icad, in just a few clicks!

Returns in Icad for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Icad investment value today

Current value as on today

₹1,08,773

Returns

₹8,773

(+8.77%)

Returns from Icad Stock

₹5,978 (+5.98%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Icad

-12%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Icad on INDmoney from India has reduced in the last 30 days as on Dec 30, 2025. -12% less investors are searching Icad in the last 30 days versus the previous period.

Global Institutional Holdings in Icad

  • Vanguard Group Inc

    4.30%

  • Arnhold & S. Bleichroeder Advisers, LLC

    2.56%

  • Renaissance Technologies Corp

    2.28%

  • BlackRock Inc

    1.33%

  • AMH Equity Ltd

    1.12%

  • Greenwood Capital Associates, LLC

    1.12%

Analyst Recommendation on Icad

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Icad(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Icad

What analysts predicted

Upside of 124.36%

Current:

$1.95

Target:

$4.38

Insights on Icad

  • Price Movement

    In the last 7 days, ICAD stock has moved up by 15.7%

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 5.02M → 4.21M (in $), with an average decrease of 16.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 1.36M → -1.80M (in $), with an average decrease of 78.5% per quarter

  • ICAD vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 56.8% return, outperforming this stock by 46.6%

  • ICAD vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 110.9% return, outperforming this stock by 184.0%

  • Price to Sales

    ForICAD every $1 of sales, investors are willing to pay $2.7, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Icad Financials in INR & Dollars

FY18Y/Y Change
Revenue
$25.6M
↓ 8.83%
Net Income
$-9.0M
↓ 36.75%
Net Profit Margin
-35.19%
↑ 15.54%
FY19Y/Y Change
Revenue
$31.3M
↑ 22.32%
Net Income
$-13.6M
↑ 50.28%
Net Profit Margin
-43.24%
↓ 8.05%
FY20Y/Y Change
Revenue
$29.7M
↓ 5.24%
Net Income
$-17.6M
↑ 29.95%
Net Profit Margin
-59.3%
↓ 16.06%
FY21Y/Y Change
Revenue
$33.6M
↑ 13.27%
Net Income
$-11.2M
↓ 36.14%
Net Profit Margin
-33.43%
↑ 25.87%
FY22Y/Y Change
Revenue
$27.9M
↓ 16.93%
Net Income
$-13.7M
↑ 21.44%
Net Profit Margin
-48.87%
↓ 15.44%
FY23Y/Y Change
Revenue
$17.3M
↓ 38.03%
Net Income
$-4.8M
↓ 64.51%
Net Profit Margin
-27.99%
↑ 20.88%
Q2 FY23Q/Q Change
Revenue
$5.9M
↑ 1.51%
Net Income
$-1.8M
↓ 53.68%
Net Profit Margin
-29.84%
↑ 35.55%
Q3 FY23Q/Q Change
Revenue
$4.1M
↓ 30.55%
Net Income
$-1.4M
↓ 21.49%
Net Profit Margin
-33.73%
↓ 3.89%
Q4 FY23Q/Q Change
Revenue
$4.7M
↑ 16.4%
Net Income
$1.4M
↓ 199.13%
Net Profit Margin
28.73%
↑ 62.46%
Q1 FY24Q/Q Change
Revenue
$5.0M
↑ 4.49%
Net Income
$-1.2M
↓ 189.72%
Net Profit Margin
-24.67%
↓ 53.4%
Q2 FY24Q/Q Change
Revenue
$5.0M
↑ 1.51%
Net Income
$-1.7M
↑ 42.31%
Net Profit Margin
-34.58%
↓ 9.91%
Q3 FY24Q/Q Change
Revenue
$4.2M
↓ 16.15%
Net Income
$-1.8M
↑ 3.57%
Net Profit Margin
-42.71%
↓ 8.13%
FY18Y/Y Change
Profit
$19.4M
↑ 6.9%
FY19Y/Y Change
Profit
$24.2M
↑ 24.69%
FY20Y/Y Change
Profit
$21.4M
↓ 11.86%
FY21Y/Y Change
Profit
$24.2M
↑ 13.53%
FY22Y/Y Change
Profit
$19.8M
↓ 18.28%
FY23Y/Y Change
Profit
$14.5M
↓ 26.63%
Q2 FY23Q/Q Change
Profit
$4.3M
↑ 5.3%
Q3 FY23Q/Q Change
Profit
$3.5M
↓ 19.04%
Q4 FY23Q/Q Change
Profit
$4.3M
↑ 20.99%
Q1 FY24Q/Q Change
Profit
$4.1M
↓ 4.93%
Q2 FY24Q/Q Change
Profit
$4.2M
↑ 4.12%
Q3 FY24Q/Q Change
Profit
$3.6M
↓ 13.82%
FY18Y/Y Change
Operating Cash Flow
$-3.9M
↓ 47.29%
Investing Cash Flow
$-316.0K
↓ 112.87%
Financing Cash Flow
$7.0M
↑ 22.82%
FY19Y/Y Change
Operating Cash Flow
$-7.1M
↑ 83.79%
Investing Cash Flow
$-306.0K
↓ 3.16%
Financing Cash Flow
$10.5M
↑ 51.0%
FY20Y/Y Change
Operating Cash Flow
$-7.0M
↓ 1.72%
Investing Cash Flow
$-474.0K
↑ 54.9%
Financing Cash Flow
$19.3M
↑ 83.4%
FY21Y/Y Change
Operating Cash Flow
$-9.4M
↑ 34.69%
Investing Cash Flow
$-587.0K
↑ 23.84%
Financing Cash Flow
$17.1M
↓ 11.59%
FY22Y/Y Change
Operating Cash Flow
$-12.8M
↑ 35.94%
Investing Cash Flow
$-534.0K
↓ 9.03%
Financing Cash Flow
$355.0K
↓ 97.92%
Q2 FY23Q/Q Change
Operating Cash Flow
$-405.0K
↓ 73.49%
Investing Cash Flow
$-221.0K
↑ 81.15%
Financing Cash Flow
$46.0K
↓ 388.31%

Icad Technicals Summary

Sell

Neutral

Buy

Icad is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Icad Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Icad Inc
Icad Inc
10.8%
54.15%
5.98%
-72.92%
-75.19%
Stryker Corporation
Stryker Corporation
-5.78%
9.1%
23.93%
37.28%
74.44%
Boston Scientific Corp.
Boston Scientific Corp.
0.25%
18.65%
56.74%
113.42%
100.0%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
7.26%
-16.18%
0.11%
-41.61%
-2.39%
Abbott Laboratories
Abbott Laboratories
-1.56%
11.42%
4.68%
-18.3%
32.25%
Medtronic Plc
Medtronic Plc
-6.7%
4.69%
-2.54%
-21.95%
-29.52%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Icad Inc
Icad Inc
NA
NA
-0.56
-0.23
-0.15
-0.08
NA
1.27
Stryker Corporation
Stryker Corporation
39.51
39.51
2.59
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
Boston Scientific Corp.
75.58
75.58
1.65
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
29.21
29.21
6.97
2.55
0.19
0.11
NA
16.18
Abbott Laboratories
Abbott Laboratories
34.95
34.95
2.23
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
Medtronic Plc
24.95
24.95
1.49
5.2
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Icad Inc
Icad Inc
Buy
$49.0M
-75.19%
NA
-12.13%
Stryker Corporation
Stryker Corporation
Buy
$140.8B
74.44%
39.51
16.34%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$134.8B
100.0%
75.58
11.26%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$44.6B
-2.39%
29.21
65.86%
Abbott Laboratories
Abbott Laboratories
Buy
$199.4B
32.25%
34.95
13.99%
Medtronic Plc
Medtronic Plc
Buy
$104.6B
-29.52%
24.95
12.06%

About Icad

icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and computed tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com.
Organization
Icad
Employees
67
CEO
Ms. Dana R. Brown
Industry
Electronic Technology

Management People of Icad

NameTitle
Ms. Dana R. Brown
President, CEO & Executive Chair
Mr. Eric Lonnqvist
Chief Financial Officer
Mr. Jonathan Go
Chief Technology Officer
Ms. Michelle Strong
Chief Operations Officer
Ms. Annette L. Heroux
Vice President of Administration
Brian Testa
Chief People Officer
Mr. Bill Keyes
Senior VP of Global Sales Operations
Mr. Vasu Avadhanula
Chief Product Officer
Mr. Peter Graham
Senior VP of North American Sales

Important FAQs about investing in Icad from India :

What is Icad share price today?

Icad share price today stands at $1.95, Open: $1.83 ; Previous Close: $1.86 ; High: $1.96 ; Low: $1.84 ; 52 Week High: $2.65 ; 52 Week Low: $1.18. The stock opens at $1.83, after a previous close of $1.86. The stock reached a daily high of $1.96 and a low of $1.84, with a 52-week high of $2.65 and a 52-week low of $1.18.

Can Indians buy Icad shares?

Yes, Indians can invest in the Icad (ICAD) from India.

With INDmoney, you can buy Icad at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Icad at zero transaction cost.

How can I buy Icad shares from India?

It is very easy to buy Icad from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Icad be purchased?

Yes, you can buy fractional shares of Icad with INDmoney app.

What are the documents required to start investing in Icad stocks?

To start investing in Icad, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Icad

Today’s highest price of Icad (ICAD) is $1.96.

Today’s lowest price of Icad (ICAD) is $1.84.

What is today's market capitalisation of Icad

Today's market capitalisation of Icad ICAD is 49.0M

What is the 52 Week High and Low Range of Icad

  • 52 Week High

    $2.65

  • 52 Week Low

    $1.18

What are the historical returns of Icad?

  • 1 Month Returns

    10.8%

  • 3 Months Returns

    54.15%

  • 1 Year Returns

    5.98%

  • 5 Years Returns

    -75.19%

Who is the Chief Executive Officer (CEO) of Icad

Ms. Dana R. Brown is the current Chief Executive Officer (CEO) of Icad.